Compare ATCH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATCH | VNRX |
|---|---|---|
| Founded | 2022 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 31.9M |
| IPO Year | 2024 | 2012 |
| Metric | ATCH | VNRX |
|---|---|---|
| Price | $0.20 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.13 |
| AVG Volume (30 Days) | 1.4M | ★ 15.1M |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $479.89 |
| Revenue Next Year | N/A | $536.25 |
| P/E Ratio | $3.36 | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $0.14 | $0.17 |
| 52 Week High | $1.92 | $0.94 |
| Indicator | ATCH | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 46.74 |
| Support Level | $0.18 | $0.17 |
| Resistance Level | $0.21 | $0.27 |
| Average True Range (ATR) | 0.01 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 70.38 | 19.64 |
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.